4-(3-(Trifluoromethyl)phenoxy)phenylthiourea, 97%, 2g

2-(4-bromo-1H-pyrazol-1-yl)-N-methylacetamide, 95.0%, 1g

tert-Butyl 4-(((benzyloxy)carbonyl)amino)-4-(2-methoxy-2-oxoethyl)piperidine-1-carboxylate, 97%, 100mg

Ethyl 6,8-dichloroimidazo[1,2-b]pyridazine-3-carboxylate, 97%, 250mg

2,4-DIFLUORO-3-NITROBENZONITRILE, 95.0%, 5g

Carrello con anelli di contrasto di fase 4x/10x e 20x/40x per microscopi invertiti Oxion Inverso

tert-Butyl 1-(morpholine-4-carbonyl)piperidin-4-ylcarbamate, 95.0%, 1g

1-(4-Fluoro-benzoyl)-piperidine-4-carboxylic acid, 95.0%, 1g

6-Chloro-3-cyclopropyl-[1,2,4]triazolo[4,3-b]pyridazine, 95.0%, 250mg

N,N'-(Hexane-1,6-diyl)bis(3-phenylprop-2-en-1-imine)>98.0%(HPLC)(T)25g

3-Amino-N-butylbenzamide, 95.0%, 1g

3,4,5-Trifluorocinnamic acid, 97.0%, 10g

1-(2-Methyl-benzyl)-pyrrolidin-3-ol, 95.0%, 500mg